In Vitro Effects of the Small-Molecule Protein Kinase C Agonists on HIV Latency Reactivation

Scientific Reports - United Kingdom
doi 10.1038/srep39032
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

CpG Methylation Controls Reactivation of HIV From Latency

Retrovirology
VirologyInfectious Diseases
2010English

The HIV Nef Protein Associates With Protein Kinase C Theta

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1996English

New Small Molecule Agonists to the Thyrotropin Receptor

Thyroid
MedicineEndocrinologyMetabolismDiabetes
2015English

RNA-induced Epigenetic Silencing Inhibits HIV-1 Reactivation From Latency

Retrovirology
VirologyInfectious Diseases
2018English

Correction: A Novel Small-Molecule Inhibitor of Protein Kinase D Blocks Pancreatic Cancer Growth in Vitro and in Vivo

Molecular Cancer Therapeutics
Cancer ResearchOncology
2010English

Dynamics of HIV Latency and Reactivation in a Primary CD4+ T Cell Model

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2014English

Protein Kinase C Directly Phosphorylates the Insulin Receptor in Vitro and Reduces Its Protein-Tyrosine Kinase Activity.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1986English

Specific Activation of the TLR1-TLR2 Heterodimer by Small-Molecule Agonists

Science advances
Multidisciplinary
2015English

Small Molecule Follicle-Stimulating Hormone Receptor Agonists and Antagonists

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy